HPV Strain Type Diagnosis by Sequencing qPCR Amplicons via Hybridisation to Tiling Arrays
Philip Day, University of Manchester, speaking at qPCR Europe 2011.
A Systematic Investigation of Candidate Breast Cancer Progression-Associated Biomarkers Identified from Omic Screens: Leveraging Antibody-Based Proteomics
Prof. William Gallagher, Chief Scientific Officer at OncoMark, speaking at Advances in Microarray Technology 2011.
High-Resolution DNA Melting Analysis for Genotyping and Mutation Scanning.
Carl Wittwer, Professor of Pathology, University of Utah, speaking at Advances in qPCR 2011.
Pharmacogenomics of Drug Disposition: From Polymorphisms to Biomarkers
Urs A. Meyer, Emeritus Professor, Biozentrum, University of Basel speaking at ADMET Europe 2011
Approaches for the Identification of New Biomarkers for Alzheimer's Disease
Christian Czech, CNS Researcher, F. Hoffman-La Roche, speaking at European Biomarkers Summit 2010.
Urine Molecular Profiling Distinguishes Health and Disease: A Fresh View on Diagnostics
Simone Koenig, Professor, University of Munster, speaking at European Biomarkers Summit 2010.
Looking Forward By Looking Backward: A Possible Step Toward Realization Of Personalized Medicine
Richard Ablin, University of Arizona, speaking at European Biomarkers Summit 2010.
An Approach to Analyzing Data From a Large Sub-Population of Single Cells
Richard Fekete, Senior Manager, Sample Preparation Department, Life Technologies, speaking at Single Analysis Summit 2010.
Biomarkers of Metabolic Syndrome in Clinical Trials
This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.